🔥🐔 BizChicken 🐔🔥
Companies Similar to CorMedix Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Autonomix Medical, Inc. Common Stock
catheter-based microchip-enabled sensing array
Autonomix Medical, Inc. is a development stage medical device company focused on advancing technologies for sensing and treating disorders related to the peripheral nervous system.
Symbol: AMIX
Recent Price: $3.98
Industry: Medical - Devices
CEO: Mr. Bradley Hauser
Sector: Healthcare
Employees: 5
Address: 21 Waterway Avenue, The Woodlands, null 77380
Phone: 713 588 6150
Last updated: 2024-12-31
Capricor Therapeutics, Inc.
CAP-1002
Capricor Therapeutics, Inc. is a clinical-stage biotechnology company specializing in developing transformative cell and exosome-based therapeutics aimed at treating and preventing a range of diseases and disorders. Their lead candidate, CAP-1002, is designed for Duchenne muscular dystrophy and cytokine storm interventions.
About | Leadership | Directors | About | About | Contact | Careers | About | About | About | About
Symbol: CAPR
Recent Price: $13.76
Industry: Biotechnology
CEO: Dr. Linda Marbán Ph.D.
Sector: Healthcare
Employees: 101
Address: 10865 Road to the Cure, San Diego, CA 92121
Phone: 310 358 3200
Leadership
- Linda Marbán, Ph.D., Chief Executive Officer and Director
- Kristi A. H. Elliott, Ph.D., Chief Science Officer
- AJ Bergmann, M.B.A., Chief Financial Officer
- Karen G. Krasney, J.D., Executive Vice President and General Counsel
- Mark Awadalla, Vice President of Clinical Operations
- Jonathan Tayco, Vice President of Program Management and Business Operations
- Minghao Sun, Ph.D., Vice President of Research and Product Development
- Yushi Feng, Ph.D., Vice President of Regulatory Affairs
- Frank Litvack M.D., FACC, Executive Chairman
- Paul G. Auwaerter, M.D., M.B.A., FIDSA, Director
- Earl M. (Duke) Collier Jr., Director
- George W. Dunbar, Jr., Director
- Philip J. Gotwals, Ph.D., Director
- Michael Kelliher, Director
- David B. Musket, Director
- Karimah Es Sabar, Director
Last updated: 2024-12-31
CVRx, Inc.
Barostim
CVRx, Inc. is a commercial-stage medical device company focusing on developing, manufacturing, and commercializing neuromodulation solutions for cardiovascular diseases, offering Barostim for heart failure patients.
Symbol: CVRX
Recent Price: $12.77
Industry: Medical - Devices
CEO: Mr. Kevin Hykes
Sector: Healthcare
Employees: 200
Address: 9201 West Broadway Avenue, Minneapolis, MN 55445
Phone: 763 416 2840
Last updated: 2024-12-31
Tenax Therapeutics, Inc.
TNX-103, TNX-102 (levosimendan), TNX-201 (imatinib)
Tenax Therapeutics, Inc. is a specialty pharmaceutical company that focuses on identifying, developing, and commercializing products for cardiovascular and pulmonary diseases. The company is involved in developing medications such as TNX-103 and TNX-102 (levosimendan) for pulmonary hypertension and heart failure, and TNX-201 (imatinib) for pulmonary arterial hypertension.
Symbol: TENX
Recent Price: $6.55
Industry: Biotechnology
CEO: Mr. Christopher T. Giordano
Sector: Healthcare
Employees: 5
Address: ONE Copley Parkway, Morrisville, NC 27560
Phone: 919 855 2100
Last updated: 2024-12-31
Tonix Pharmaceuticals Holding Corp.
TNX-1500, TNX-2900, TNX-801, TNX-1840, TNX-1850, TNX-3500
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company that focuses on developing therapies for immunology, rare diseases, infectious diseases, and central nervous system disorders. Key products include TNX-1500 for organ transplant and autoimmune diseases, TNX-2900 for Prader-Willi syndrome, and TNX-801 for smallpox prevention.
Symbol: TNXP
Recent Price: $0.36
Industry: Biotechnology
CEO: Dr. Seth Lederman M.D.
Sector: Healthcare
Employees: 103
Address: 26 Main Street, Chatham, NJ 07928
Phone: 862 799 8599
Last updated: 2024-12-31
Conduit Pharmaceuticals Inc.
AZD1656, AZD5904
Conduit Pharmaceuticals Inc. is a clinical stage specialty biopharmaceutical company focusing on unmet medical needs in autoimmune disease and idiopathic male infertility. Founded in 2019 and based in San Diego, California, it operates as a subsidiary of Corvus Capital Limited.
Symbol: CDT
Recent Price: $0.08
Industry: Biotechnology
CEO: Dr. David Joszef Tapolczay
Sector: Healthcare
Employees: 7
Address: 4995 Murphy Canyon Road, San Diego, CA 92134
Phone: 760 471 8536
Last updated: 2024-12-31
Celldex Therapeutics, Inc.
therapeutic monoclonal and bispecific antibodies
Celldex Therapeutics is a biopharmaceutical company focused on developing therapeutic monoclonal and bispecific antibodies for treating inflammatory diseases and cancers.
About | About | Management | Directors | About | Contact | About | Contact | Careers | Careers | Careers | Careers | Jobs | Careers | About | About
Symbol: CLDX
Recent Price: $25.12
Industry: Biotechnology
CEO: Mr. Anthony S. Marucci M.B.A.
Sector: Healthcare
Employees: 160
Address: Perryville III Building, Hampton, NJ 08827
Phone: 908 200 7500
Leadership
- Anthony S. Marucci, Founder, President, Chief Executive Officer and Director
- Tibor Keler, Ph.D., Founder, Executive Vice President and Chief Scientific Officer
- Diane C. Young, M.D., Senior Vice President and Chief Medical Officer
- Elizabeth Crowley, Senior Vice President, Chief Product Development Officer
- Sam Martin, Senior Vice President and Chief Financial Officer
- Ronald A. Pepin, Ph.D., Senior Vice President and Chief Business Officer
- Richard Wright, Ph.D., Senior Vice President and Chief Commercial Officer
- Sarah Cavanaugh, Senior Vice President, Corporate Affairs and Administration
- Margo Heath-Chiozzi, M.D., Senior Vice President, Regulatory Affairs
- Freddy A. Jimenez, Esq., Senior Vice President and General Counsel
- Karen L. Shoos, J.D., Former Chair, Director of Operations, Maryland Tech Council Venture Mentoring Services Program
- Keith L. Brownlie, Former Partner, Ernst & Young LLP
- Herbert J. Conrad, Former President, Roche Pharmaceuticals US
- James J. Marino, J.D., Former Partner, Dechert LLP
- Harry H. Penner, Jr., J.D., L.L.M., Former Chairman and CEO, Nascent Bioscience
- Cheryl L. Cohen, President, CLC Consulting; Former Chief Commercial Officer of Medivation, Inc.
- Dr. Garry Neil, Chief Executive Officer; Chair of the Board, Avalo Therapeutics
- Rita Jain, M.D., Former Executive Vice President, Chief Medical Officer of ChemoCentryx, Inc.
- Carl June, M.D.,
- Michel Nussenzweig, M.D., Ph.D.,
- Marc E. Rothenberg M.D., Ph.D.,
- Joseph Schlessinger, Ph.D.,
- Louis Weiner, M.D.,
Last updated: 2024-12-31
Corcept Therapeutics Incorporated
Korlym (mifepristone)
Corcept Therapeutics discovers, develops, and commercializes drugs for treating severe metabolic, oncologic, and neuropsychiatric disorders in the United States, including their product Korlym for Cushing's syndrome.
Symbol: CORT
Recent Price: $50.85
Industry: Biotechnology
CEO: Dr. Joseph K. Belanoff M.D.
Sector: Healthcare
Employees: 352
Address: 149 Commonwealth Drive, Menlo Park, CA 94025
Phone: 650 327 3270
Last updated: 2024-12-31
Corbus Pharmaceuticals Holdings, Inc.
lenabasum, CRB-601, CRB-602
Corbus Pharmaceuticals Holdings, Inc., is a biopharmaceutical company focused on immune modulators for immuno-oncology and fibrosis diseases, developing products like lenabasum and monoclonal antibodies for cancer and fibrosis.
About | Leadership | About | About | Contact | About | Contact | Contact | About | About | About
Symbol: CRBP
Recent Price: $12.08
Industry: Biotechnology
CEO: Dr. Yuval Cohen Ph.D.
Sector: Healthcare
Employees: 19
Address: 500 River Ridge Drive, Norwood, MA 02062
Phone: 617 963 0100
Leadership
- Alan Holmer, Chairman of the Board
- Yuval Cohen, Ph.D., Chief Executive Officer, Director
- Anne Altmeyer, Ph.D., Director
- Yong Ben, M.D., MBA, Director
- Rachelle Jacques, Director
- John Jenkins, M.D., Director
- Pete Salzmann, M.D., MBA, Director
- Winston Kung, MBA, Director
- Dr. Dominic Smethurst, MA MRCP, Chief Medical Officer
- Sean Moran, CPA, MBA, Chief Financial Officer
- Christina Bertsch, VP of Human Resources
- Dr. Dominic Smethurst, Chief Medical Officer
Last updated: 2024-12-31
CorMedix Inc.
Defen Cath/Neutrolin
Cor Medix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for infectious and inflammatory diseases, with a lead product candidate aimed at preventing catheter-related infections.
Symbol: CRMD
Recent Price: $8.10
Industry: Biotechnology
CEO: Mr. Joseph Todisco MBA
Sector: Healthcare
Employees: 82
Address: 300 Connell Drive, Berkeley Heights, NJ 07922
Phone: 908 517 9500
Last updated: 2024-12-31
CervoMed Inc.
neflamapimod
Cervo Med Inc. is a clinical-stage biotechnology company focused on developing and commercializing drug treatments for neurodegenerative diseases, including neflamapimod for conditions like dementia with Lewy bodies, Alzheimer's diseases, and brain stroke recovery.
Symbol: CRVO
Recent Price: $2.39
Industry: Biotechnology
CEO: Dr. John J. Alam M.D.
Sector: Healthcare
Employees: 8
Address: 20 Park Plaza, Boston, MA 02116
Phone: 617-744-4400
Last updated: 2024-12-31
ICU Medical, Inc.
medical devices
ICU Medical, Inc. develops, manufactures, and sells medical devices for infusion therapy and critical care applications worldwide.
About | About | About | News | About | About | About | About | News | News | News | News | About | Contact | Contact | Careers | Jobs | Locations | About | About | About | Jobs | About | Careers | Careers | About | Careers | Careers | Careers | About | About | About | About | About
Symbol: ICUI
Recent Price: $154.20
Industry: Medical - Instruments & Supplies
CEO: Mr. Vivek Jain
Sector: Healthcare
Employees: 14000
Address: 951 Calle Amanecer, San Clemente, CA 92673
Phone: 949 366 2183
Last updated: 2024-12-31
Indaptus Therapeutics, Inc.
Decoy20
Indaptus Therapeutics, Inc. is a pre-clinical biotechnology company focusing on the development of anti-cancer and anti-viral immunotherapy products, with its lead clinical candidate, Decoy20, targeting lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as viral infections.
Symbol: INDP
Recent Price: $0.87
Industry: Biotechnology
CEO: Mr. Jeffrey A. Meckler
Sector: Healthcare
Employees: 7
Address: 3 Columbus Circle, New York, NY 10019
Phone: 347 480 9760
Last updated: 2024-12-31
Nephros, Inc.
Water Solutions
Nephros, Inc. develops and sells high performance water solutions to medical and commercial markets, offering products for water filtration, pathogen detection, and renal health.
ESG | About | Leadership | Contact | About | About | About | Events | Careers | About | About | About | About
Symbol: NEPH
Recent Price: $1.48
Industry: Medical - Instruments & Supplies
CEO: Mr. Robert Banks
Sector: Healthcare
Employees: 31
Address: 380 Lackawanna Place, South Orange, NJ 07079
Phone: 201 343 5202
Leadership
- Robert Banks, President & Chief Executive Officer
- Judy Krandel, Chief Financial Officer
- Michael Milman, VP, R&D & Manufacturing
- Vashone Thomas, VP, Quality, Regulatory, & Human Resources
- Judy Mazzini, Controller
- Brianne McGuire, Director, Brand, Marketing, & Business Development
- Devorah Serkin, Senior Director, Revenue Operations
- Alfred Vargas, Director, Operations
- Beth Johnson, Director, Research & Development
Last updated: 2024-12-31
Nurix Therapeutics, Inc.
NX-2127, NX-5948, NX-1607, NX-0255
Nurix Therapeutics, Inc. is a biopharmaceutical company that focuses on developing small molecule therapies for cancer and immune disorders, with products targeting BTK and CBL-B proteins. The company collaborates with Gilead Sciences and Sanofi.
Symbol: NRIX
Recent Price: $18.64
Industry: Biotechnology
CEO: Dr. Arthur T. Sands M.D., Ph.D.
Sector: Healthcare
Employees: 284
Address: 1700 Owens Street, San Francisco, CA 94158
Phone: 415 660 5320
Last updated: 2024-12-31
scPharmaceuticals Inc.
FUROSCIX
sc Pharmaceuticals Inc. is a pharmaceutical company focused on developing and commercializing pharmaceutical products, with a lead product candidate, FUROSCIX, aimed at treating congestion in heart failure patients using an on-body infusor.
About | Leadership | Contact | Contact | Careers | About | About | About | About | Careers | Careers | Careers | Careers | About | About | About
Symbol: SCPH
Recent Price: $3.50
Industry: Biotechnology
CEO: Mr. John H. Tucker
Sector: Healthcare
Employees: 135
Address: 2400 District Avenue, Burlington, MA 01803
Phone: 617 517 0730
Leadership
- John H. Tucker, President and Chief Executive Officer
- Rachael Nokes, Chief Financial Officer
- Mike Hassman, Senior Vice President, Technical Operations
- John Mohr, Pharm.D., FIDP, Senior Vice President, Clinical Development and Medical Affairs
- William T. Abraham, MD,
- Mette Kirstine Agger, Co-Founder & CEO, 7TM Pharma A/S
- Minnie V. Baylor-Henry, President, B-Henry & Associates
- Sara Bonstein, CFO, Insmed Incorporated
- Frederick Hudson, Former Partner in Charge of KPMG’s Largest Healthcare Industry Audit Practice Located in the Mid-Atlantic Region
- Jack A. Khattar, Founder, President & Chief Executive Officer, Supernus Pharmaceuticals
- Leonard D. Schaeffer, Founding Chairman & CEO, Wellpoint
- Klaus Veitinger, MD, PhD, Venture Partner, Orbimed
- Dan Bensimhon, MD, Medical Director Advanced Heart Failure & Mechanical Circulatory Support Program, Cone Health, Greensboro, NC
- G. Michael Felker, MD, Chief, Heart Failure Service, Division of Cardiology, Duke University School of Medicine
- Marv Konstam, MD, Professor of Medicine, Tufts University School of Medicine, Chief Physician Executive of the Cardiovascular Center at Tufts Medical Center
- W. Frank Peacock, MD, FACEP, FACC, FESC, Professor, Vice Chair of Research, Department of Emergency Medicine, Baylor College of Medicine, Ben Taub General Hospital
- Stuart Russell, MD, Regional Director of Heart Failure Program, Duke University School of Medicine
- James E. Udelson, MD, Chief, Division of Cardiology, Tufts Medical Center, Professor of Medicine and Radiology Tufts University School of Medicine
- William Weintraub, MD, Director of Outcomes Research, MedStar Heart and Vascular Institute
Last updated: 2024-12-31
Catalent, Inc.
Drug and health product solutions
Catalent, Inc. develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products globally. It operates through segments like Biologics, Softgel and Oral Technologies, among others.
About | About | Leadership | About | About | DEI | Contact | Careers | Careers | Careers | About | About | Careers | Careers | Careers | DEI | Careers | Benefits | Careers | About | About | About | About
Symbol: CTLT
Recent Price: $63.48
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Alessandro Maselli
Sector: Healthcare
Employees: 17000
Address: 14 Schoolhouse Road, Somerset, NJ 08873
Phone: 732 537 6200
Last updated: 2024-12-31
DiaMedica Therapeutics Inc.
DM199
Dia Medica Therapeutics Inc. is a clinical stage biopharmaceutical company developing treatments for neurological and kidney diseases, including their lead drug candidate DM199 for chronic kidney disease and acute ischemic stroke.
Symbol: DMAC
Recent Price: $5.34
Industry: Biotechnology
CEO: Mr. Dietrich John Pauls MBA
Sector: Healthcare
Employees: 18
Address: Two Carlson Parkway, Minneapolis, MN 55447
Phone: 763 612 6755
Leadership
- Rick Pauls, President & CEO
- Lorianne Masuoka, Chief Medical Officer
- Scott Kellen, Chief Financial Officer
- Ambarish Shah, Ph.D., Chief Technology Officer
- Dominic Cundari, Chief Commercial Officer
- David Wambeke, Chief Business Officer
- Rebekah de Vitry Fries, Vice President of Clinical Operations
- Dr. Paolo Madeddu, MD, Senior Scientific Advisor and KLK1 Expert
Last updated: 2024-12-31
Lantheus Holdings, Inc.
DEFINITY, Techne Lite, Xenon-133, Neurolite, Cardiolite, Thallium-201, Gallium-67, AZEDRA, Automated Bone Scan Index, Cobalt (Co 57), RELISTOR
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide.
Symbol: LNTH
Recent Price: $89.13
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Brian A. Markison
Sector: Healthcare
Employees: 834
Address: 331 Treble Cove Road, North Billerica, MA 01862
Phone: 978 671 8001
Leadership
- Brian Markison, Chief Executive Officer
- Paul Blanchfield, President
- Jeff Humphrey, MD, Chief Medical Officer
- Robert J. Marshall Jr., Chief Financial Officer
- Amanda Morgan, Chief Commercial Officer
- Daniel Niedzwiecki, Chief Administrative Officer, General Counsel and Corporate Secretary
- Jean-Claude Provost, MD, Chief Science Officer
- Jamie Spaeth, Chief People Officer
- Cheryl Ball, Senior Vice President, Strategy and Enterprise Planning
- Dorothy Barr, Senior Vice President, Manufacturing and Technical Operations
- Kim Brown, Chief Accounting Officer
- Lee Anne Howe, Chief Information Officer
- Linda Lennox, Chief of Staff & Vice President, Corporate Communications
- Joann Nestor, Senior Vice President, Legal Affairs
- Andrea Sabens, Vice President, Business Optimization
- Carol Walker, Senior Vice President, Quality
- Mary Anne Heino, Chairperson of the Board
- Minnie Baylor-Henry, Director
- Gérard Ber, PhD, Director
- Julie Eastland, Director
- Samuel Leno, Director
- Heinz Mäusli, Director
- Julie McHugh, Director
- Gary J. Pruden, Director
- James H. Thrall, MD, Director
Last updated: 2024-12-31
Nuvectis Pharma, Inc.
NXP800, NXP900
Nuvectis Pharma, Inc., is a biopharmaceutical company that focuses on developing precision medicines for treating serious unmet medical needs in oncology. It is working on products like NXP800, a heat shock factor 1 pathway inhibitor, and NXP900, a drug candidate targeting Proto-oncogene c-Src and YES1 kinases.
Symbol: NVCT
Recent Price: $5.14
Industry: Biotechnology
CEO: Mr. Ron Bentsur M.B.A.
Sector: Healthcare
Employees: 13
Address: 1 Bridge Plaza, Fort Lee, NJ 07024
Phone: 201 614 3150
Last updated: 2024-12-31